- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
(This note is not part of the Order)
This Order appoints 22nd April 2003 as the date on and after which qualifying expenditure incurred by a company on direct research and development, sub-contracted research and development or contributions to independent research and development may give rise to entitlement to relief under Schedule 13 to the Finance Act 2002 (tax relief for expenditure on vaccine research etc) (“Schedule 13”). Paragraph 28(1) of Schedule 13 provides that the day appointed in respect of Schedule 13 may be a day not earlier than 1st April 2002.
By virtue of paragraph 5 of Schedule 14 to the 2002 Act (tax credits under Schedule 13: consequential amendments), that Schedule has effect in relation to tax credits payable under Schedule 13 incurred on and after the day appointed by the Treasury under paragraph 28 of that Schedule.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: